Henry James International Management Inc. Ascendis Pharma A/S Transaction History
Henry James International Management Inc.
- $280 Million
- Q3 2024
A detailed history of Henry James International Management Inc. transactions in Ascendis Pharma A/S stock. As of the latest transaction made, Henry James International Management Inc. holds 21,351 shares of ASND stock, worth $2.77 Million. This represents 1.14% of its overall portfolio holdings.
Number of Shares
21,351
Previous 24,497
12.84%
Holding current value
$2.77 Million
Previous $3.34 Million
4.55%
% of portfolio
1.14%
Previous 1.21%
Shares
18 transactions
Others Institutions Holding ASND
# of Institutions
243Shares Held
58.8MCall Options Held
250KPut Options Held
377K-
Ra Capital Management, L.P. Boston, MA9.71MShares$1.26 Billion20.22% of portfolio
-
Westfield Capital Management CO LP Boston, MA5.13MShares$666 Million3.62% of portfolio
-
Avoro Capital Advisors LLC New York, NY4.99MShares$648 Million11.21% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI4.41MShares$573 Million1.03% of portfolio
-
Janus Henderson Group PLC London, X04.19MShares$543 Million0.33% of portfolio
About Ascendis Pharma A/S
- Ticker ASND
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,810,200
- Market Cap $7.24B
- Description
- Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...